Prompt Healing of Erosive Oral Lichen Planus Lesion after Combined Corticosteroid Treatment with Locally Injected Triamcinolone Acetonide Plus Oral Prednisolone.

Ru-Cheng Kuo,Hung-Pin Lin,Andy Sun,Yi-Ping Wang
DOI: https://doi.org/10.1016/j.jfma.2012.01.014
IF: 3.871
2013-01-01
Journal of the Formosan Medical Association
Abstract:Background/Purpose: Erosive oral lichen planus (EOLP) is a T-cell-mediated inflammatory disease that is refractory to treat. This study tested whether local injection of triamcinolone acetonide plus oral administration of low- or medium-dose prednisolone could hasten the healing of EOLP lesions.Methods: In this study, 50 EOLP patients were treated with local injection of Kenacort A (40 mg triamcinolone acetonide once weekly for 3 and 2 weeks for 30 major and 20 minor EOLP patients, respectively) plus oral administration of prednisolone (25-30 mg and 15-20 mg of prednisolone once daily for 2 weeks for 30 major and 20 minor EOLP patients, respectively). The oral administration of prednisolone was tapered to 5 mg per day and stopped in 7 days. Then, the patients were treated with topical Dexaltin (0.1% dexamethasone, once or twice per daily) and oral administration of vitamin Bc (one capsule twice daily) thereafter.Results: After 3-week treatments, the 30 major EOLP patients showed complete response (lack of detectable erosive or ulcerative lesion with absence or regression of reticular or papular OLP) in 27 cases (90%) and partial response (reduction of erosive or ulcerative lesion by at least 30% in diameter with regression of reticular or papular OLP) in cases (10%); and 20 minor EOLP patients demonstrated complete response in 18 cases (90%) and partial response in two cases (10%). However, all the 45 complete response major or minor EOLP patients showed recurrence of erosive or ulcerative lesion after 3-24 (mean 12) months of follow-up.Conclusion: Prompt and complete healing of the EOLP lesions could be achieved in a relative short period of time after treatment with our protocol. Although complete response EOLP Lesions recurred after a follow-up period of 3-24 months, patients did have an average remission period of 12 months after treatment with our protocol. Copyright (C) 2012, Elsevier Taiwan LLC Et Formosan Medical Association. All rights reserved.
What problem does this paper attempt to address?